TrialArthritis & rheumatology (Hoboken, N.J.)2018

Brief Report: A Phase IIb Trial of a Novel Extended-Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis.

Philip G Conaghan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.